The expanding demand for controlled immunological investigation and therapeutic design has spurred significant progress in recombinant growth factor generation. IL-1A, IL-1B, IL-2, and IL-3, each possessing unique physiological roles, are frequently generated using various expression systems, including microbial hosts, animal cell populations, and